Find (1S)-1-[3-[3-[(Dimethylamino)carbonyl]phenoxy]-4-nitrophenyl]ethyl P,P-bis(1-aziridinyl)phosphinate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

0

FDA Orange Book

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ast-3424, 2097713-69-2, Odafosfamide, Odafosfamide [inn], Schembl20870082, Schembl29392358
Molecular Formula
C21H25N4O6P
Molecular Weight
460.4  g/mol
InChI Key
NWGZZGNICQFUHV-HNNXBMFYSA-N
FDA UNII
C2T9S468D3

(1S)-1-[3-[3-[(Dimethylamino)carbonyl]phenoxy]-4-nitrophenyl]ethyl P,P-bis(1-aziridinyl)phosphinate
Odafosfamide is the S-isoform of odafosfamide, a small-molecule nitro-benzene, aldo-keto reductase 1C3 (AKR1C3)-activated prodrug of N,N'-bisethylenephosphoramidate, a DNA bis-alkylating agent, with potential antineoplastic activity. Upon intravenous administration, odafosfamide is converted to its active form by AKR1C3, which is upregulated in certain tumor cell types while not expressed in normal healthy cells. The active metabolite selectively binds to and alkylates DNA in AKR1C3-overexpressing tumor cells, resulting in DNA base pair mismatching, interstrand crosslinking and inhibition of DNA repair and synthesis, cell-cycle arrest, and apoptosis. As the expression of AKR1C3 is restricted to tumors, Odafosfamide is selectively converted to its active metabolite in tumor cells only while its conversion in normal, healthy tissue is absent; this allows for an increased cytotoxic effect of the alkylating agent in tumor cells while decreasing its toxicity.
1 2D Structure

(1S)-1-[3-[3-[(Dimethylamino)carbonyl]phenoxy]-4-nitrophenyl]ethyl P,P-bis(1-aziridinyl)phosphinate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[5-[(1S)-1-[bis(aziridin-1-yl)phosphoryloxy]ethyl]-2-nitrophenoxy]-N,N-dimethylbenzamide
2.1.2 InChI
InChI=1S/C21H25N4O6P/c1-15(31-32(29,23-9-10-23)24-11-12-24)16-7-8-19(25(27)28)20(14-16)30-18-6-4-5-17(13-18)21(26)22(2)3/h4-8,13-15H,9-12H2,1-3H3/t15-/m0/s1
2.1.3 InChI Key
NWGZZGNICQFUHV-HNNXBMFYSA-N
2.2 Other Identifiers
2.2.1 UNII
C2T9S468D3
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Ast-3424

2. 2097713-69-2

3. Odafosfamide

4. Odafosfamide [inn]

5. Schembl20870082

6. Schembl29392358

7. C2t9s468d3

8. Ex-a6317

9. Obi-3424, (s)-

10. Th-2870, (s)-

11. (1s)-1-{3-[3-(dimethylcarbamoyl)phenoxy]-4-nitrophenyl}ethyl Bis(aziridin-1-yl)phosphinate

12. 3-[5-[(1s)-1-[bis(aziridin-1-yl)phosphoryloxy]ethyl]-2-nitrophenoxy]-n,n-dimethylbenzamide

13. Phosphinic Acid, P,p-bis(1-aziridinyl)-, (1s)-1-[3-[3-[(dimethylamino)carbonyl]phenoxy]-4-nitrophenyl]ethyl Ester

2.4 Create Date
2018-10-02
3 Chemical and Physical Properties
Molecular Weight 460.4 g/mol
Molecular Formula C21H25N4O6P
XLogP32.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count8
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area108
Heavy Atom Count32
Formal Charge0
Complexity737
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty